Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Akriti Seth
Strides has acquired 18 ANDAs from Pharmaceutics International, as well as exclusive marketing rights to a levothyroxine sodium candidate. Through this agreement, the Indian company plans to expand its niche offerings.
Teva UK’s director of secondary care, Andrew Ellis, who has been a member of the British Biosimilars Association’s steering group, has now been appointed as its new chair.
As Europe struggles to maintain an adequate and sustainable supply of affordable medicines, industry and regulators come together to discuss the key factors causing shortages and solutions to overcome them.
Simplification of pharmacovigilance processes is required not only in Europe but also globally, delegates to Medicines for Europe’s 2020 pharmacovigilance conference heard. Industry is also calling for greater transparency to better engage with the public on pharmacovigilance issues.
Amneal has laid out ambitious plans for 2020 to deliver value and volume growth, including by expanding internationally, augmenting organic growth through M&A and capitalizing on its pipeline of ANDAs and development projects. The firm will seek to build on its launch of 38 products in 2019 as well as benefiting from recent key appointments to its board.
Abbott’s Established Pharmaceuticals business saw double-digit organic growth in the fourth quarter of 2019 on the back of its “unique branded generic strategy in emerging markets,” particularly in Latin America and Asia.